Inventor · disambiguated record
Eric Escobar-Cabrera
Also filed as: ESCOBAR-CABRERA ERIC
14 granted patents·17 pending applications·132 citations·filing 2011–2025
92Inventor score
Top patents by PatentIndex Score
31 records- 0196US10000576B1Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2018·Granted Jun 19, 2018·23 cites·30 claims
- 0296US9574010B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2012·Granted Feb 21, 2017·48 cites·79 claims
- 0395US10457742B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2017·Granted Oct 29, 2019·17 cites·32 claims
- 0490US9988460B2Crystal structures of heterodimeric Fc domainsZYMEWORKS INC·Filed 2017·Granted Jun 5, 2018·8 cites·15 claims
- 0590US2025122305A1Bispecific antigen binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0689US11325981B2Bispecific antigen-binding constructs targeting Her2ZYMEWORKS INC·Filed 2018·Granted May 10, 2022·2 cites·19 claims
- 0789US10947319B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2014·Granted Mar 16, 2021·5 cites·18 claims
- 0889US9732155B2Crystal structures of heterodimeric Fc domainsZYMEWORKS INC·Filed 2013·Granted Aug 15, 2017·12 cites·15 claims
- 0988US10875931B2Stable heterodimeric antibody design with mutations in the Fc domainZYMEWORKS INC·Filed 2017·Granted Dec 29, 2020·4 cites·8 claims
- 1085US11028182B2Antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2016·Granted Jun 8, 2021·2 cites·28 claims
- 1185US2025197527A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 1281US12215166B2Bispecific antigen binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2022·Granted Feb 4, 2025·0 cites·23 claims
- 1381US9296815B2Antibodies with enhanced or suppressed effector functionD ANGELO IGOR·Filed 2011·Granted Mar 29, 2016·9 cites·14 claims
- 1476US11965036B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 1576US11098105B2Heteromultimers with reduced or silenced effector functionZYMEWORKS INC·Filed 2014·Granted Aug 24, 2021·2 cites·16 claims
- 1671US2024327815A1Multivalent polypeptide constructs capable of binding viral spike proteins and methods of using the sameZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 1769US12227591B2Antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Feb 18, 2025·0 cites·19 claims
- 1869US2021277150A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 1965US2020087414A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS INC·Filed 2019·Application pending·0 cites
- 2058US2025019440A1Immunomodulatory trispecific t cell engager fusion proteinsZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 2158US2024294667A9Heterodimeric iga fc constructs and methods of use thereofZYMEWORKS BC INC·Filed 2021·Application pending·0 cites
- 2255US2024409604A9Stabilized tcr constructs and methods of useZYMEWORKS BC INC·Filed 2021·Application pending·0 cites
- 2354US2023331809A1Fusion proteins comprising a ligand-receptor pair and a biologically functional proteinZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 2454US2013336973A1Heteromultimer Constructs of Immunoglobulin Heavy Chains with Mutations in the Fc DomainZYMEWORKS INC·Filed 2013·Application pending·0 cites
- 2551US2024294646A1HETERODIMERIC Fc VARIANTS SELECTIVE FOR Fc GAMMA RIIBZYMEWORKS BC INC·Filed 2021·Application pending·0 cites
- 2647US2016257763A1Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domainZYMEWORKS INC·Filed 2016·Application pending·0 cites
- 2746US2023303715A1IMMUNOGLOBULIN Fc REGION VARIANTS COMPRISING STABILITY-ENHANCING MUTATIONSZYMEWORKS BC INC·Filed 2021·Application pending·0 cites
- 2844US2020048371A1Tumor antigen presentation inducer constructs and uses thereofZYMEWORKS INC·Filed 2018·Application pending·0 cites
- 2943US2025235548A1Antibody-drug conjugates targeting napi2b and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 3042US2025277030A1Anti-napi2b antibodies and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 3142US2016159921A1Antibodies with enhanced or suppressed effector functionZYMEWORKS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Escobar-Cabrera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →